Skip to main content
. Author manuscript; available in PMC: 2023 Sep 18.
Published in final edited form as: J Urol. 2021 Dec 2;207(4):823–831. doi: 10.1097/JU.0000000000002343

Table 3.

Risk factors of upgrading to ≥GG3 after MRI-guided confirmatory biopsy in 506 cases

HR (95% CI)

Family history of PCa 1.58 (1.02–2.44)
No. pos systematic cores (reference, 0):
 1 0.95 (0.45–2.00)
 ≥2 1.27 (0.65–2.50)
No. pos targeted cores (reference, 0):
 Neg MRI (no targeted cores) 1.46 (0.79–2.70)
 1 2.75 (1.25–6.03)
 ≥2 3.38 (1.65–6.91)
GG (reference, no cancer):
 1 1.40 (0.57–3.44)
 2 2.93 (1.05–8.19)

Values in bold are statistically significant.